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Summary
Campylobacter rectus is associated with fetal exposure and low-birth weight in humans. C. rectus
also invades placental tissues and induces fetal intrauterine growth-restriction (IUGR) in mice,
along with Toll-like receptors (TLR4) overexpression, suggesting that TLR4 may mediate
placental immunity and IUGR in mice. To test this hypothesis we examined the effect of in
vitroTLR4 neutralization in trophoblastic proinflammatory activity and studied the IUGR
phenotype in a congenic TLR4-mutant mouse strain after in vivo C. rectus infection. Human
trophoblasts were pretreated with TLR4 neutralizing antibodies and infected with C. rectus; pro-
inflammatory cytokine production was assessed by cytokine multiplexing assays. Neutralizing
TLR4 antibodies significantly impaired the production of pro-inflammatory cytokines in
trophoblastic cells after infection in a dose-dependent manner. We used a subcutaneous chamber
model to provide a C. rectus challenge in BALB/cAnPt (TLR4Lps-d) and wild-type(WT) females.
Females were mated with WT or TLR4Lps-dmales once/week; pregnant mice were infected at
(E)7.5 and sacrificed at (E)16.5 to establish IUGR phenotypes. Maternal C. rectus infection
significantly decreased fetal weight/length in infected WT when compared to sham WT
controls(P<0.05, ANOVA). However, infected TLR4Lps-d−/− mice did not show statistically
significant differences in fetal weight and length when compared to WT controls(P>0.05).
Furthermore, heterozygous TLR4Lps-d −/+fetuses showed IUGR phenotype rescue. We concluded
that TLR4 is an important mediator of trophoblastic proinflammatory responses and TLR4-
deficient fetuses do not develop IUGR phenotypes after C. rectus infection, suggesting that
placental cytokine activation is likely to be mediated by TLR4 during low birth weight/preterm
delivery pathogenesis.
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Periodontal diseases (gingivitis and periodontitis) are among the most common infectious
diseases affecting up to 50% of Americans (Albandar, 2002). As a chronic infection in
nature, periodontitis exposes the host to microbial challenge for extended periods of time
leading to a persistent oral inflammatory response that ultimately causes alveolar bone
resorption and tooth loss. Concomitantly, the susceptible host is exposed to repeated
bacteremias and systemic inflammatory mediators that have been shown to contribute to the
pathogenesis of some systemic diseases including atherosclerosis and cardiovascular
diseases (Beck and Offenbacher, 2005). Periodontitis has also been associated with an
increased risk for preterm delivery (PTD) and preeclampsia in different human populations,
suggesting that maternal periodontitis and the associated bacteria may represent an
important systemic stressor for both the mother and fetus (Ruma et al., 2008). Moreover,
maternal oral pathogens may reach the developing fetus through hematogenous
dissemination (Han et al., 2009). In particular, Campylobacter rectus is an exclusively oral
Gram negative anaerobe that has experimentally shown the competence to selectively
translocate to the fetoplacental unit and operate as a fetal infectious agent eliciting
prematurity and growth restriction in animals (Bobetsis et al., 2007;Offenbacher et al.,
2005). Furthermore, our studies have found that maternal C. rectus infection in the presence
of low serum antibody is associated with high fetal exposure and preterm delivery, as
demonstrated by high fetal IgM antibody responses (Madianos et al., 2001). Fetal exposure
to oral organisms is associated with higher levels of several pro-inflammatory mediators in
cord blood, including IL-1β, IL-6 and TNFα, especially among preterm births. However, the
underlying biological mechanisms leading to fetal-placental inflammation and preterm
delivery after C. rectus exposure still remain to be elucidated.
PTD is defined by the World Health Organization as birth at less than 37 completed
gestational weeks(1970). PTD is still the major cause of neonatal mortality and morbidity in
the world, associated with low birth weight (<2500 grams) and fetal intrauterine growth-
restriction(IUGR) (MacDorman et al., 2005). Preterm delivery can be initiated by multiple
mechanisms including infection, local inflammation, uteroplacental ischemia, hemorrhage,
stress and other immunologically mediated processes (Romero et al., 2006). Although
precise triggering mechanisms have not been established, the development of a
proinflammatory condition is a common pathway that centralizes all multiple PTD risk
factors(Romero et al., 1994). Particularly, uterine infections account for 25–40% of preterm
births and they are strongly linked to local proinflammatory cytokines, metalloproteinases
and prostaglandins. The increased expression of these inflammatory mediators may lead to
membrane weakening, early membrane rupture and uterine contraction initiation (Shoji et
al., 2007). Such proinflammatory responses are likely to be initiated and/or mediated by the
host innate immune system via activation of Toll-like receptors (TLRs) which have a
primary role in pathogen recognition and innate immunity initiation(Brikos and O’Neill,
2008). TLRs receptors bind to several microbial components or end-products known as
pathogen-associated molecular patterns (PAMPs). After binding and recognition, TLRs are
able to trigger an array of signaling pathways that ultimately activate downstream molecules
such as nuclear factor kB (NF-kB) and interferon regulatory factor 3 (IRF-3)(Uematsu and
Akira, 2006), which in turn mediate the expression of several proinflammatory cytokines as
demonstrated in several tissues, including the maternal-fetal interface(Koga and Mor, 2008).
TLR regulation has been suggested to play a critical role in mediating the innate immune
response during pregnancy, which in turn has significant implications for the success or
failure of pregnancies in both early and late gestation (Patni et al., 2007). To date, about 13
mammalian Toll-like receptors homologues have been identified and designated, and their
expression has been described in the human placenta, being dominantly expressed by
trophoblasts (Abrahams et al., 2004; Holmlund et al., 2002; Kumazaki et al., 2004). Notably,
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trophoblasts have also been proposed to be involved in coordinating the immune response
during both embryonic implantation, placental development and immunosurveillance (Mor,
2008).
Our overall goal is to better understand the maternal and fetal biological mechanisms
leading to preterm delivery in response to C. rectus infection. Specifically, we have
hypothesized that C. rectus induces a placental innate inflammatory response mediated by
Toll-like receptors (TLRs). This hypothesis is based on previous studies using C. rectus as a
model of systemic infection in pregnant mice, in which we have demonstrated: 1) the
systemic dissemination of C. rectus from distant sites of infection (dorsal subcutaneous
chamber and oral cavity) to the placenta(Arce et al., 2010); 2) Increased local placental
inflammatory response confined to the decidua along with placental structural alterations
(wider junctional zone)(Offenbacher et al., 2005); 3) Fetal intrauterine growth restriction
induction (lighter and shorter fetal pups)(Yeo et al., 2005); 4) Altered gene expression along
with down-regulation of several imprinted genes (i.e. Insulin growth-factor 2) via changes in
DNA methylation patterns (hypermethylation) (Bobetsis et al., 2007; Bobetsis et al., 2010);
5)increased trophoblastic TLR-4 expression (2-fold) after C. rectus oral infection(Arce et al.,
2009) and 6) in vitro trophoblastic production of TNFα and IL-6 in a dose-dependent
response to C. rectus infection (Arce et al., 2010). Based upon these experimental
observations, we believe that the local placental inflammatory response may play a
significant role in mediating IUGR. However, it is still unclear whether TLRs activation
mediate the placental inflammatory responses and IUGR in response to C. rectus exposure
in vivo. The purpose of this investigation was to determine the role of TLR-4 in mediating in
vitro (human trophoblasts) cytokine synthesis following C. rectus challenge and to




The human trophoblast cell line BeWo (ATCC CCL-98) was used for cytokine assays
(Pattillo and Gey, 1968). BeWo cells are the first human trophoblastic endocrine cell type to
be maintained in continuous culture, initiated from a malignant gestational choriocarcinoma
of the fetal placenta. Briefly, BeWo cells were grown in Ham’s F12K medium with 2 mM
L-glutamine adjusted to contain 10% fetal bovine serum (FBS) according to ATCC
propagation instructions. Cells were grown in T-25 flasks (Corning, Life Sciences, MA) or
onto cover slips placed in 6-well plates for the experiments. All cells were grown at 37°C in
10% CO2.
Bacterial cultures
C. rectus 314 aliquots were maintained in Wilkins Chalgren anaerobic broth medium (WC
broth; DSMZ, Braunschweig, Germany) containing 10% skim milk at −80°C. C. rectus
aliquots were reconstituted on PRAS ETSA plates (Enriched Tryptic Soy Agar from
Anaerobe Systems, Morgan Hill CA). Bacteria were anaerobically grown under 5% CO2,
10% H2-85% N2 atmosphere at 37°C for 4–6 days. Bacterial suspensions were prepared
from primary cultures at their log phase of growth and resuspended in tissue culture medium
without antibiotics (in vitro experiments) or PBS (in vivo experiments) to an optical density
of 1.00 (600 nm) determined by spectrophotometry (Cecil Instruments, Cambridge, UK)
corresponding to 1×109 bacteria/ml.
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In vitro trophoblast infection assays
BeWo cells were grown onto 6-well plates until 80–90% confluency. BeWo cell monolayers
were also washed 3 times with cell culture medium without antibiotics prior to inoculation
with bacteria. Bacterial cells were added to obtain a multiplicity of infection (MOIs) of 500
bacteria/BeWo cell, after which plates were centrifuged at 250 ×g for 5 min, incubated for
12h at 37°C in 10% CO2 and washed with PBS. This time point and MOI were chosen based
on previous experiments demonstrating a dose-dependent pro-inflammatory activity (Arce et
al., 2010). All experiments were done in triplicates and in two independent times.
TLR 4 neutralization
Additional infection experiments were performed to evaluate the effect of using a TLR4
neutralizing antibody in the proinflammatory phenotype. Briefly, BeWo cells were treated
with 1 or 2ug of anti-human TLR4 antibody (AF1478 goat IgG, R&D systems, Minneapolis
MN) for 2 hours before infection. Then BeWo cell monolayers were washed 3 times with
cell culture medium without antibiotics and were followed by the infection protocol as
explained before. The concentration for human TLR4 bioactivity neutralization for this
antibody was chosen based on the lowest dose recommended by the manufacturer (1.5 μg/
mL). Additional experiments were also performed to include ultrapure E. coli LPS (0111:B4
strain, Invivogen, San Diego, CA) using 1 μg/well as a positive control for the production of
proinflammatory cytokines.
Cytokine multiplexing assays
infected cells and non-infected controls were washed 3 times with PBS to remove non-
adhered cells. The quantification of IL-6 and TNFα in cell supernatants was performed by
means of xMAP multiplexing cytokine assays. Briefly, cell supernatants were collected after
timed infection, centrifuged at 1500 × g for 5 min and then frozen until analysis.
Multianalyte kits for human and mouse IL-6 and TNFα were used following the
manufacturer’s instructions (Fluorokine MAP Kits, R&D systems, Minneapolis, MN).
Experiments were performed in duplicates and two independent assays
Congenic TLR4-deficient mouse model of systemic C. rectus infection
All procedures were in accordance with the animal welfare guidelines and approved by the
University of North Carolina-Chapel Hill Institutional Animal Care and Use Committee.
The mouse infection model used was similar to that described before (Yeo et al., 2005).
BALB/cAnPt TLR4-deficient (TLR4Lps-d) mice and congenic BALB/cByJ Wild-type (WT)
controls were obtained from the Jackson Laboratory (C.C3-Tlr4Lps-d/J stock number 002930
and BALB/cByJ wild type stock number 001026, The Jackson Laboratory, Bar Harbor,
MA). All mice were housed under controlled and standardized conditions with 12-hour
light-dark cycles. Regular mouse diet and water were provided ad libitum. Females were
enrolled in the experiments at approximately 6 weeks of age and immediately had a steel
chamber implanted subcutaneously as previously described (Yeo et al., 2005). After one
month of healing, females were mated overnight with males of the same or different
background (6 females per group). The next morning, females were removed from the male
cages and examined for vaginal plugs. If a plug was found, that day was recorded as
embryonic day E0.5. At E7.5, pregnant mice received an intra-chamber injection of 100 μl
of 109 CFU/mL live C. rectus in PBS. Mice were then sacrificed at E16.5 and fetuses (n=47
from homozygous TLR4lps-d−/− infected dams and n=49 from heterozygous TLR4lps-d+/−
infected dams) and their respective placental tissues were collected for further analyses
(fetal length/weight). For comparison purposes, we included fetal weight and length data
from experiments using sham-infected WT controls (n=143) and C. rectus-infected WT
mice (n=37) that were subjected to the same experimental protocol.
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A minimal sample size of 6 mice per group was calculated [power (1−β) of >0.90% with
alpha-error threshold of (α) = 0.05] based on our previous results on fetal growth restriction
after C. rectus systemic infection at E16.5 (Arce et al., 2010). Continuous variables were
expressed as means and standard errors. mRNA fold differences between the infected cells
(test) and non-infected controls were compared using the unpaired T-test. Protein
concentration differences were compared using the one-way Anova test. Mean placental/
fetal weight and fetal length values for all groups were compared using the Anova (Kruskal-
wallis) test with Dunn’s post-hoc comparisons. The frequency of resorptions and litter sizes
in all groups were compared by using the Chi-square test. The threshold for statistical
significance was set at a P-value less than 0.05. No corrections were made for multiple
comparisons. All analyses were performed using GraphPad software (San Diego California
USA).
Results
Neutralizing anti-human TLR 4 antibodies impaired the production of pro-inflammatory
cytokines in BeWo cells after C. rectus infection in a dose-dependent manner
We evaluated the production of the pro-inflammatory cytokines IL-6 and TNFα by
multiplexing assays in response to C. rectus treatment and the effects of anti- TLR4
neutralizing antibodies on cytokine synthesis. As depicted in Figure 1, there was a dose-
dependent suppression of the cytokine production by the addition of anti-TLR4AB in BeWo
cells. For example, for total IL-6 production in response to MOI-500 there was a statistically
significant decrease to 46.4% when cells were pre-treated with 1ug TLR4AB (34.0±9.02 pg/
mL), and a further decrease to 17.1% was evident when using 2ug of TLR4AB (12.5±4.18,
P<0.05, Anova). A similar trend was also observed for TNFα, in which total production was
decreased to 48.1% when using 1ug TLR4AB (4.9±1.80) and to 33.6% when using 2ug
TLRAB (3.4±0.32, P<0.05, Anova). We also evaluated the pro-inflammatory responses to a
classical TLR4 agonist (E. coli LPS) as a positive control for the experiment, finding a
significant decrease for both IL-6 (21.5%) and TNFα (31%).
TLR4-deficient fetuses are less susceptible to IUGR after maternal C. rectus systemic
infection
We sought to evaluate the in vivo effect of a deficient TLR4 receptor congenic murine strain
on IUGR after systemic C. rectus exposure. In terms of litter size and frequency of fetal
resorptions, there were no statistical differences among all experimental groups (P>0.05,
Chi-square). This suggests there were no effects of TLR4 deficiency on implantation.
However, differences in fetal weight are shown in Figure 2. WT fetuses from sham-infected
dams had an average weight of 0.47±0.005 grams. When infected with C. rectus, WT dams
delivered IUGR fetuses that had an average weight of 0.42±0.009. However, when
TLR4lps-ddams were mated with males of the same genetic background and then infected
with C. rectus, the TLR4lps-d−/− homozygous fetuses appeared not to be affected by the
infection as their average weight of 0.46±0.010 did not statistically differ from the WT
control dams (P>0.05, Kruskal-wallis). Furthermore, when TLR4lps-ddams were mated with
a male from a different genetic background (WT) and after C. rectus infection, the IUGR
phenotype of TLR4lps-d+/− heterozygous fetuses had an average fetal weight of 0.43±0.008
was statistically different from the WT controls (P<0.05, Kruskal-wallis) and intermediate
between WT and homozyogousTLR4lps-d−/−. A very similar trend was also observed for the
fetal length (expressed in cms) as illustrated in Figure 3. For example, WT controls had an
average size of 1.440±0.008 and when WT dams were infected by C. rectus fetuses were
found to be significantly smaller (1.229±0.01, P<0.05, Kruskal-wallis). However, infected
homozygous TLR4lps-d−/− fetuses were larger than infected WT (1.396±0.019) and were not
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statistically different from WT controls (P>0.05). On the other hand, infected heterozygous
TLR4lps-d+/− mice showed smaller fetuses (1.251±0.012) that were significantly different
from fetuses from the WT controls.
Discussion
Preterm delivery is the major cause of neonatal morbidity/mortality in the world, affecting
12.5% of live births the United States (Abrahams, 2008). Even though the etiology of
pregnancy complications remains somewhat elusive, there is strong evidence supporting the
association between infections and PTD, mostly mediated by systemic inflammation
(Goldenberg et al., 2000; Romero et al., 2007). These observations in humans have been
confirmed by a number of animal models demonstrating a PTD phenotype in response to
experimental infection with heat-killed, live bacteria or isolated bacterial components that
are able to trigger an inflammatory cascade at the fetoplacental level (Elovitz, 2006; Han et
al., 2004).
Toll-like receptors (TLRs) have gained a lot of attention in PTD research in the last decade.
TLRs are a family of transmembrane proteins that play a key role in activating the innate
immune system in different organs including the fetal maternal interphase (Uematsu and
Akira, 2006). In particular, TLR receptors type 4 (TLR4) has been found to be particularly
important because TLR4 senses the major Gram negative component: lipopolysaccharide
(LPS). LPS delivered systemically, intrauterine or intra-amniotically triggers PTD in
vivo(Elovitz and Mrinalini, 2004; Liu et al., 2007). Furthermore, mice deficient for TLR4
show protection against bacterial and LPS-induced PTD (Wang and Hirsch, 2003; Elovitz et
al., 2003). Experimental TLR4 antagonism suppresses pro-inflammatory responses to
bacteria including oral microorganisms in vivo(Liu et al., 2007;ms Waldorf et al., 2008). At
the cellular level, Trophoblasts are thought to be primary sentinel cells that are involved in
microbial clearance preventing microbial translocation of infectious agents from mother to
fetus (Levy, 2007). Upon recognition of microbes through TLRs, trophoblasts coordinate
NK cells and neutrophils recruitment to the maternal-fetal interface, a key feature in PTD
and pre-eclampsia pathogenesis (Abrahams and Mor, 2005). Trophoblastic cells upregulate
the secretion of pro-inflammatory chemokines (IL-8 and MCP-1) and cytokines (IL1β, IL6
and TNFα) following the ligation of TLR-4 by bacterial LPS, exerting trophoblastic cells to
differentially modulate the maternal immune system both during normal pregnancy and in
the presence of an intrauterine infection (Mor, 2008).
A similar proinflammatory phenotype has also been observed in our experiments using the
oral periodontal pathogen Campylobacter rectus. C. rectus is an orally Gram negative
anaerobe and motile bacterium that plays a pathogenic role in human periodontitis (Rams et
al., 1993; Yokoyama et al., 2008). C. rectus shows a wide array of virulence factors
including LPS (Ogura et al., 1995; Ogura et al., 1996; Takiguchi et al., 1996). C. rectus is
part of the Campylobacteraceae family which has been associated with other diseases
showing important pro-inflammatory mechanistic similarities such as Campylobacter jejuni
in acute gastroenteritis (Allos, 2001) and Campylobacter fetus in sheep and cattle abortion
(Guerrant et al., 1978; Macuch and Tanner, 2000; Fujihara et al., 2006). In animal models,
C. jejuni and C. fetus infections result in impaired fetal development and intrauterine growth
restriction (O’Sullivan et al., 1988a; O’Sullivan et al., 1988b). Noteworthy, our in vivo and
in vitro C. rectus infection experiments in pregnant mice and placental cells have
consistently shown an upregulation of maternal inflammatory serum markers following
challenge(Yeo et al., 2005), as well as placental translocation. In culture C. rectus is capable
of trophoblastic cell invasion. These observations suggest a pathway that involves
translocation of C. rectus to placental tissue, activation of trophoblastic TLR4 consequent
placental pro-inflammatory response that ultimately result in IUGR (Arce et al., 2010).
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We previously reported a dose-dependent response for human IL-6 and TNFα production at
the protein levels in human BeWo trophoblasts in response to C. rectus in vitro infection
(Arce et al., 2010). In this report we provide new data that demonstrate that the antagonism
of TLR4 by means of a neutralizing TLR4 antibody (TLR4AB) impairs the activation of
inflammatory responses (Fig. 1). When BeWo cells were pre-treated with 2 different doses
(1 or 2 ug) of TLR4AB for 2 hours before live bacterial exposure, a statistically significant
dose-dependent inhibition in the level of IL-6 was observed (Fig 1a, P<0.05, Anova for both
doses when compared to Cr MOI500). A similar trend was observed for TNFα production
(Fig. 1b, P<0.05, Anova for 2ug dose when compared to Cr MOI500). The ligation of TLR4
by the antagonist also induced some degree of cytokine activation that was not statistically
significant when compared to the blank control (P>0.05, Anova), but may indicate a slight
partial agonist activity. Collectively, these results strongly suggest a TLR4 dependent
activity of BeWo cells in response to C. rectus infection. TLR4 experimental antagonism has
also demonstrated significant effects on a PTD phenotype in different animal models. For
example, TLR4 receptors have been shown to mediate the murine placental inflammatory
response and fetal death to Fusobacterium nucleatum, another oral periodontal bacterial
species associated with PTD (Liu et al., 2007). Moreover, the selective antagonism of TLR4
inhibits inflammation and preterm uterine contractility in a nonhuman intra-amniotic LPS
model in Rhesus monkeys (ms Waldorf et al., 2008).
Lastly, we aimed to evaluate our current murine model of systemic bacterial exposure of C.
rectus in pregnant mice on a congenic TLR4-mutant mouse strain on a Balb/C background.
As reported before, a remote subcutaneous maternal C. rectus infection increases fetal
growth restriction in Balb/C mice (Yeo et al., 2005; Offenbacher et al., 2005). As shown in
Figures 2 and 3, when WT dams were infected with C. rectus, there was a statistically
significant decrease in fetal weight (12.5%) and length reduction (14.7%)(P<0.05, Kruskal-
wallis). However, in the absence of functional TLR4 in homozygous fetuses, no IUGR was
detected as TLR4Lps-d−/− fetuses were not statistically different from sham-infected WT
controls for both weight and length(P>0.05, Dunn’s). Furthermore, when fetuses carried
only 1 allele with a functional TLR4 in the heterozygous TLR4Lps-d+/− group the IUGR
phenotype was again observed as these fetuses were significantly different from WT
controls (P<0.05, Dunn’s) and comparable to C. rectus-infected WT dams (P>0.05, Dunn’s).
To our interpretation, the observed phenotype in our experiments completely supported our
hypothesis that TLR4 receptors are mediating IUGR after systemic C. rectus infection in
mice. This is also in agreement with Liu et al (Liu et al., 2007), who reported that the fetal
death rate was significantly reduced in TLR4-deficient mice on a TLR4 knock/out strain
following F. nucleatum infection.
In conclusion, TLR4 neutralization leads to a significant reduction in trophoblastic pro-
inflammatory activity can be observed in vitro. Moreover, in the absence of a functional
TLR4 in mice seems to lead to decreased susceptibility to C. rectus infection (IUGR) in
vivo. Collectively, these results suggest that the placental proinflammatory responses are
mediated by TLR4 during low birth weight/preterm delivery pathogenesis. We also
speculate that TLR4-antagonistic therapies may be used to specifically block infection-
associated inflammation during pregnancy as proposed by others (Abrahams, 2008; Liu et
al., 2007). TLR4 as a therapeutic target may provide new future studies that could have
promise to bring new anti-inflammatory agents for the treatment or prevention of bacterial-
induced, preterm delivery.
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Figure 1. TLR4 neutralization in trophoblastic cells affects cytokine production after in vitro C.
rectus infection
BeWo cells were pre-treated with 1ug or 2ug of a TLR4AB showing a dose-response
decrease in IL-6 and TNFα production. Cr=C. rectus. * P<0.05
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Figure 2. Fetal weight is not significantly affected in TLR4-deficient fetuses from C. rectus-
infected dams
Box-plots depicting average ± standard errors. The overall Kruskal-Wallis test was highly
statistically significant (P<0.0001). Dunn’s post-hoc multiple comparison tests found
statistically significant differences (P<0.05) for Control WT vs. C. rectus-infected WT,
Control WT vs. C. rectus-infected TLR4Lpsd+/− and C. rectus-infected WT vs. C. rectus-
infected TLR4Lpsd−/−. There were not significant differences (P>0.05) for Control WT vs. C.
rectus-infected TLR4Lpsd−/−, C. rectus-infected WT vs. C. rectus-infected TLR4Lpsd+/− and
C. rectus-infected TLR4Lpsd−/− vs. C. rectus-infected TLR4Lpsd+/−. Solid lines indicate
statistical significance (P<0.05). Dotted lines indicate no statistical significance (P>0.05).
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Figure 3. Fetal length is unaffected in TLR4-deficient fetuses from C. rectus-infected dams
Box-plots depicting average ± standard errors. The overall Kruskal-Wallis test was highly
statistically significant (P<0.0001). Dunn’s post-hoc multiple comparison tests found
statistically significant differences (P<0.05) for Control WT vs. C. rectus-infected WT,
Control WT vs. C. rectus-infected TLR4Lpsd+/−, C. rectus-infected WT vs. C. rectus-infected
TLR4Lpsd−/− and for C. rectus-infected TLR4Lpsd−/− vs. C. rectus-infected TLR4Lpsd+/−.
There were no significant differences for Control WT vs. C. rectus-infected TLR4Lpsd−/−
and C. rectus-infected WT vs. C. rectus-infected TLR4Lpsd+/−. Solid lines indicate statistical
significance (P<0.05). Dotted lines indicate no statistical significance(P>0.05).
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